BridgeMD
Compares treatment options for Nuclear Sclerosis of the Lens
Official title This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal
ClinicalTrials.gov ID: NCT07468877
What this study is testing
- What it's testing
- This clinical trial compares two phacoemulsification systems used in a bilateral cataract surgery subjects, in order to study CDE and Ultrasound time during cataract removal
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Healthy patients 18 years or older undergoing uncomplicated sequential bilateral cataract surgery with phacoemulsification and IOL implantation
- Expected to undergo sequential cataract surgery in both eyes
- Must have bilateral nuclear sclerosis cataracts classified using LOCS III as grade 3 or above (see appendix III)
- Both eyes will be operated on by the same surgeon
- Have the ability to consent for study and procedure planned
You likely can't join if
- Patients under 18 years of age.
- Complex cataract cases involving zonulopathy (e.g., pseudoexfoliation syndrome, traumatic zonular weakness) that may require use of zonular support...
- Require mechanical pupil expanding devices (e.g., iris hooks, Malyugin rings, etc.)
- Undergoing femtosecond laser-assisted lens fragmentation.
- Surgical complications, in the opinion of the investigator, occurring either intraoperatively or postoperatively (including capsule tears, iris...
- Prior ocular surgery (including intraocular, oculoplastic, corneal or refractive surgical procedure) performed within the last 3 months or at any...
See the full eligibility criteria
- Healthy patients 18 years or older undergoing uncomplicated sequential bilateral cataract surgery with phacoemulsification and IOL implantation
- Expected to undergo sequential cataract surgery in both eyes
- Must have bilateral nuclear sclerosis cataracts classified using LOCS III as grade 3 or above (see appendix III)
- Both eyes will be operated on by the same surgeon
- Have the ability to consent for study and procedure planned
- Patients under 18 years of age.
- Complex cataract cases involving zonulopathy (e.g., pseudoexfoliation syndrome, traumatic zonular weakness) that may require use of zonular support devices during surgery (e.g. capsular hooks) and/or implantation of...
- Require mechanical pupil expanding devices (e.g., iris hooks, Malyugin rings, etc.)
- Undergoing femtosecond laser-assisted lens fragmentation.
- Surgical complications, in the opinion of the investigator, occurring either intraoperatively or postoperatively (including capsule tears, iris trauma, or decentered intraocular lens) and not attributable to the study...
- Prior ocular surgery (including intraocular, oculoplastic, corneal or refractive surgical procedure) performed within the last 3 months or at any time that in the investigator's clinical judgment, if it interferes with...
- Presence of endothelial cell dystrophies and/or corneal comorbidities.
- History of intraocular inflammation (e.g., uveitis, iritis).
- History of retinal edema or presence of a clinically significant epiretinal membrane that, in the investigator's clinical judgment, may interfere with the outcome measures of this study.
- History of retinal surgery (e.g.retinal detachment repair, membrane peel) involving vitrectomy.
- Dense brunescent cataract that in the investigator's clinical judgment, may interfere with the outcome measures of this study.
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.